Equity Incentive Plan (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2016 Plan				2019 Plan
	Nine Months Ended September 30, 2020		Nine Months Ended September 30, 2019		Nine Months Ended September 30, 2020		Nine Months Ended September 30, 2019
Total fair value of stock options granted	$	-	$	2,492	$	9,241	$	-
Total fair value of options vested		-		1,439		-		-

Summary of Valuation Models of Fair Value of Awards Granted To Employees and Non-Employees Under 2016 Plan

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employees under both the 2019 Plan and the 2016 Plan:

	Nine Months Ended September 30, 2020	Nine Months Ended September 30, 2019
Expected volatility	37.63% - 41.24%	36.92%
Expected term (in years)	6.0	6.5
Dividend yield	0.00%	0.00%
Risk free interest rate	1.43% - 0.30%	2.42%

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Company’s Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	Three Months Ended September 30, 2020		Three Months Ended September 30, 2019		Nine Months Ended September 30, 2020		Nine Months Ended September 30, 2019
Cost of revenues	$	339	$	144	$	1,020	$	442
General and administrative		350		127		841		1,045
Research and development		65		24		205		67
Sales and marketing		159		116		486		346
Total	$	913	$	411	$	2,552	$	1,900

Restricted Stock Units [Member]

Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity under the 2019 Plan:

Description	RSUs Outstanding
Balance at December 31, 2019		-
Granted		1,402,312
Forfeited		(73,827	)
Expired		-
Balance at September 30, 2020		1,328,485

2019 Plan [Member]

Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Options Outstanding, December 31, 2019		514,710		$	9.90		10.0	$	-
Granted		4,137,750			8.49
Forfeited		(248,101	)		9.08
Expired		-
Options Outstanding, September 30, 2020		4,404,359		$	8.46		9.3	$	-
Options Exercisable, September 30, 2020		-		$	-		-	$	-

(1) Aggregate intrinsic value represents the difference between the estimated fair value of the underlying Common Stock (as defined below) and the exercise price of outstanding, in-the-money options. There were no in-the-money options as of September 30, 2020 or December 31, 2019.